Memantin Ratiopharm Gmbh

Memantine, the active ingredient in Memantin Ratiopharm Gmbh, is a NMDA receptor antagonist presented as an oral dosage form for oral use. It treats Alzheimer’s disease in adults with mild to moderate cognitive impairment.

GNH USA supplies Memantin Ratiopharm Gmbh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantine is an NMDA receptor antagonist used in the management of neurodegenerative conditions.

Alzheimer's disease (mild to moderate): improves cognition and daily functioning. Alzheimer's disease (moderate to severe): supports functional abilities and may slow decline. Behavioral symptoms of Alzheimer’s disease: may reduce agitation and improve patient cooperation.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue - Confusion - Hypertension

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (rash, swelling, difficulty breathing) - Hallucinations or psychosis - Cardiac arrhythmias

Memantine should be used with caution in patients with the following considerations: - Renal impairment: dose adjustment may be required. - Hepatic impairment: monitor liver function. - History of seizures: monitor for increased seizure activity. - Concomitant use with other NMDA antagonists: avoid additive neurotoxicity. - Pregnancy: safety unknown; use only if clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Memantine may interact with several medications that affect the central nervous system or electrolyte balance.

Major Interactions (Avoid): - Amantadine: increased risk of neurotoxicity. - Other NMDA antagonists (e.g., ketamine): additive CNS effects. - High‑dose anticholinesterases: may reduce therapeutic benefit.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may enhance dizziness. - Diuretics: may affect blood pressure control. - Antihypertensive agents: potential for additive hypotensive effect.